The vaccine maker is competing with well-established rivals in markets that have a mix of demand issues as well as commercial and structural headwinds, as the biotech looks to establish new growth drivers.
Tag Archive for: Moderna
The regulator on Thursday said the mRNA vaccines, Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax, will better protect against currently circulating variants as COVID continues to surge in many parts of the U.S.
Pfizer’s, GSK’s, and Moderna’s competition for arms for their new respiratory syncytial virus (RSV) vaccines is on Wall Street’s watch list for when the companies report earnings later this week.
Langer played a crucial role in the development of Moderna’s messenger RNA COVID vaccine, which is the biotech’s only commercial product.
Following a disappointing IPO and the loss of Moderna’s gene editing contract, Metagenomi’s Chief Scientific Officer Luis Borges is departing the biotech.
The U.S. government has awarded $176 million to Moderna to advance development of its bird flu vaccine, the company said on Tuesday, as concerns rise over a multi-state outbreak of H5N1 virus in dairy cows and infections of three dairy workers since March.
Today the company announced that its respiratory syncytial virus (RSV) shot mRESVIA showed 50% efficacy in preventing RSV after 18 months.
A committee of outside experts to the U.S. CDC are set to vote on whether to expand the age group of adults who should receive respiratory syncytial virus (RSV) vaccines this year, as GSK battles rival Pfizer and new entrant Moderna to keep its top position in the market.
The experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people aged 12 years and older.
In the study, the combination using messenger RNA technology generated greater antibodies than currently marketed traditional flu vaccines and Moderna’s Spikevax mRNA COVID shot, the company said.